Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Deer antler stem cell fluid helps regenerate tissue better than fat-derived stem cell fluid.

Intense pulsed light treatment mainly damages pigmented hair parts but spares stem cells, allowing hair to regrow.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Spironolactone is used in dermatology to treat skin conditions related to hormones, but is not safe for pregnant women or men.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Autophagy changes the protein makeup of hair.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

The transgene likely activated an oncogene or interrupted a tumor suppressor gene, causing melanoma in mice.

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Adding a second method to PROTACs could improve cancer treatment.

Proper diet management is crucial for phenylketonuria patients to avoid severe health issues.

Stem cell offspring help control their parent stem cells, affecting tissue health, healing, and cancer.

Lower levels of certain genes in hair cells improve hair loss treatment outcomes.

Melanocyte stem cells are crucial for skin pigmentation and have potential in disease modeling and regenerative medicine.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

miR-199a-3p controls hair growth and is linked to alopecia areata.